W E Berdel Selected Research

Etoposide (VP 16)

11/2003	Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
1/2002	Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.
1/2001	Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W E Berdel Research Topics

Disease

27	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 12/2000
22	Neoplasms (Cancer) 03/2018 - 04/2000
7	Leukemia 01/2018 - 08/2007
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2018 - 01/2001
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2017 - 03/2012
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2016 - 09/2003
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2012 - 01/2001
3	Breast Neoplasms (Breast Cancer) 06/2008 - 06/2004
2	Lung Neoplasms (Lung Cancer) 03/2018 - 02/2016
2	Hemorrhage 03/2016 - 03/2005
2	Hodgkin Disease (Hodgkin's Disease) 03/2016 - 01/2005
2	Residual Neoplasm 02/2015 - 09/2001
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2014 - 03/2001
2	Acute Promyelocytic Leukemia 12/2009 - 12/2000
2	Mucositis 09/2008 - 11/2003
2	Hematologic Neoplasms (Hematological Malignancy) 07/2002 - 09/2001
2	Multiple Myeloma 09/2001 - 04/2000
1	Carcinogenesis 01/2018
1	Pathologic Complete Response 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017
1	Splenomegaly 03/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2016
1	Cardiotoxicity 04/2012
1	Lymphatic Metastasis 06/2009
1	Stomatitis 09/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2008
1	Infections 09/2008
1	Ovarian Neoplasms (Ovarian Cancer) 10/2006
1	Adenocarcinoma 09/2006

Drug/Important Bio-Agent (IBA)

5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2007 - 04/2000
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2000
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 12/2009
4	Cyclin A1IBA 04/2001 - 05/2000
3	Imatinib Mesylate (Gleevec)FDA Link 11/2017 - 03/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2006 - 12/2000
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2005 - 09/2001
3	Etoposide (VP 16)FDA LinkGeneric 11/2003 - 01/2001
3	Ifosfamide FDA LinkGeneric 11/2003 - 01/2001
2	Blood Group Antigens (Blood Groups)IBA 03/2018 - 02/2016
2	AntigensIBA 01/2018 - 02/2016
2	ErbB Receptors (EGF Receptor)IBA 10/2017 - 09/2006
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 05/2008 - 01/2001
2	Cisplatin (Platino)FDA LinkGeneric 11/2003 - 01/2001
2	Thalidomide (Thalomid)FDA Link 09/2003 - 09/2001
2	Carboplatin (JM8)FDA LinkGeneric 01/2002 - 01/2001
2	Semaxinib (SU5416)IBA 11/2001 - 07/2001
2	CyclinsIBA 01/2001 - 12/2000
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018
1	Amsacrine (AMSA)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Biotin (Vitamin H)FDA Link 01/2018
1	Adaptor Protein Complex 3IBA 01/2018
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2018
1	EstersIBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	InterferonsIBA 11/2017
1	Monoclonal AntibodiesIBA 10/2017
1	Gemcitabine FDA Link 10/2017
1	nimotuzumabIBA 10/2017
1	Heparin (Liquaemin)FDA LinkGeneric 03/2016
1	NivolumabIBA 03/2016
1	Azacitidine (5 Azacytidine)FDA Link 03/2016
1	CarbohydratesIBA 02/2016
1	CamptothecinIBA 01/2016
1	EWS-FLI fusion proteinIBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	TrabectedinIBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	fludarabineIBA 05/2014
1	Gemtuzumab (Mylotarg)FDA Link 04/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2009
1	Indicators and Reagents (Reagents)IBA 06/2009
1	Capsules (Microcapsules)IBA 09/2008
1	Methotrexate (Mexate)FDA LinkGeneric 09/2008
1	Fibroblast Growth Factor 7 FDA Link 09/2008
1	ParaffinIBA 05/2008
1	M40 (M 40)IBA 05/2008
1	AnthracyclinesIBA 03/2008
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2008
1	Angiopoietin-1IBA 09/2007
1	Angiopoietin-2IBA 09/2007
1	tyrosine receptor (receptor, tyrosine)IBA 08/2007
1	Retinoic Acid Receptor alphaIBA 08/2007
1	Phosphotransferases (Kinase)IBA 08/2007
1	Transcription Factors (Transcription Factor)IBA 08/2007
1	Bevacizumab (Avastin)FDA Link 06/2007
1	Semaphorins (Semaphorin)IBA 11/2006
1	Neuropilin-1IBA 11/2006
1	Vascular Endothelial Growth FactorsIBA 11/2006
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2006
1	Gefitinib (Iressa)FDA Link 09/2006

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 01/2016 - 05/2000
14	Therapeutics 01/2018 - 01/2000
6	Induction Chemotherapy 03/2016 - 03/2001
3	Stem Cell Transplantation 11/2016 - 01/2004
2	Cell Transplantation 11/2017 - 05/2015
2	Transplantation 10/2012 - 10/2003
2	Adjuvant Chemotherapy 06/2008 - 05/2008
1	Hematopoietic Stem Cell Transplantation 05/2015